| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |